<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>etoposide phosphate</title><link>http://www.unboundmedicine.com/medline/ebm/research/etoposide_phosphate</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>The role of biotechnology in the production of the anticancer compound podophyllotoxin.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19521861/full_citation/The_role_of_biotechnology_in_the_production_of_the_anticancer_compound_podophyllotoxin_</link><description>Lata H, Mizuno CS, Moraes RM <br/><span class="title">The role of biotechnology in the production of the anticancer compound podophyllotoxin. [Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.]</span><br/><span class="source" title="Methods in molecular biology (Clifton, N.J.)">Methods Mol Biol 2009.:387-402.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19521861/abstract/The_role_of_biotechnology_in_the_production_of_the_anticancer_compound_podophyllotoxin_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19521861/full_citation/The_role_of_biotechnology_in_the_production_of_the_anticancer_compound_podophyllotoxin_">Full Citation</a> | <a href="http://dx.doi.org/10.1007/978-1-60327-287-2_31">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19521861/The_role_of_biotechnology_in_the_production_of_the_anticancer_compound_podophyllotoxin_">Find Related Articles</a> </description></item><item><title>A Review on Hemisynthesis, Biosynthesis, Biological Activities, Mode of Action, and Structure-Activity Relationship of Podophyllotoxins: 2003-2007.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19149581/full_citation/A_Review_on_Hemisynthesis_Biosynthesis_Biological_Activities_Mode_of_Action_and_Structure_Activity_Relationship_of_Podophyllotoxins:_2003_2007_</link><description>Xu H, Lv M, Tian X <br/><span class="title">A Review on Hemisynthesis, Biosynthesis, Biological Activities, Mode of Action, and Structure-Activity Relationship of Podophyllotoxins: 2003-2007. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current medicinal chemistry">Curr Med Chem 2009; 16(3):327-349.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19149581/abstract/A_Review_on_Hemisynthesis_Biosynthesis_Biological_Activities_Mode_of_Action_and_Structure_Activity_Relationship_of_Podophyllotoxins:_2003_2007_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19149581/full_citation/A_Review_on_Hemisynthesis_Biosynthesis_Biological_Activities_Mode_of_Action_and_Structure_Activity_Relationship_of_Podophyllotoxins:_2003_2007_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19149581/A_Review_on_Hemisynthesis_Biosynthesis_Biological_Activities_Mode_of_Action_and_Structure_Activity_Relationship_of_Podophyllotoxins:_2003_2007_">Find Related Articles</a> </description></item><item><title>Primary meningeal CNS lymphoma treated with intra-arterial chemotherapy and blood-brain barrier disruption.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18758913/full_citation/Primary_meningeal_CNS_lymphoma_treated_with_intra_arterial_chemotherapy_and_blood_brain_barrier_disruption_</link><description>Macnealy MW, Newton HB, McGregor JM, et al. <br/><span class="title">Primary meningeal CNS lymphoma treated with intra-arterial chemotherapy and blood-brain barrier disruption. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of neuro-oncology">J Neurooncol 2008 Aug 30.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18758913/abstract/Primary_meningeal_CNS_lymphoma_treated_with_intra_arterial_chemotherapy_and_blood_brain_barrier_disruption_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18758913/full_citation/Primary_meningeal_CNS_lymphoma_treated_with_intra_arterial_chemotherapy_and_blood_brain_barrier_disruption_">Full Citation</a></description></item><item><title>[Interest of lignans in prevention and treatment of cancers.]</title><link>http://www.unboundmedicine.com/medline/ebm/record/18466729/full_citation/[Interest_of_lignans_in_prevention_and_treatment_of_cancers_]</link><description>Lamblin F, Hano C, Fliniaux O, et al. <br/><span class="title">[Interest of lignans in prevention and treatment of cancers.] [JOURNAL ARTICLE]</span><br/><span class="source" title="Medecine sciences : M/S">Med Sci (Paris) 2008 May; 24(5):511-520.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18466729/abstract/[Interest_of_lignans_in_prevention_and_treatment_of_cancers_]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18466729/full_citation/[Interest_of_lignans_in_prevention_and_treatment_of_cancers_]">Full Citation</a></description></item><item><title>Successful treatment with etoposide phosphate in patients with previous etoposide hypersensitivity.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18337441/full_citation/Successful_treatment_with_etoposide_phosphate_in_patients_with_previous_etoposide_hypersensitivity_</link><description>Collier K, Schink C, Young AM, et al. <br/><span class="title">Successful treatment with etoposide phosphate in patients with previous etoposide hypersensitivity. [Journal Article]</span><br/><span class="source" title="Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners">J Oncol Pharm Pract 2008 Mar; 14(1):51-5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18337441/abstract/Successful_treatment_with_etoposide_phosphate_in_patients_with_previous_etoposide_hypersensitivity_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18337441/full_citation/Successful_treatment_with_etoposide_phosphate_in_patients_with_previous_etoposide_hypersensitivity_">Full Citation</a></description></item><item><title>Thanatop: a novel 5-nitrofuran that is a highly active, cell-permeable inhibitor of topoisomerase II.</title><link>http://www.unboundmedicine.com/medline/ebm/record/17483360/full_citation/Thanatop:_a_novel_5_nitrofuran_that_is_a_highly_active_cell_permeable_inhibitor_of_topoisomerase_II_</link><description>Polycarpou-Schwarz M, Müller K, Denger S, et al. <br/><span class="title">Thanatop: a novel 5-nitrofuran that is a highly active, cell-permeable inhibitor of topoisomerase II. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Cancer research">Cancer Res 2007 May 1; 67(9):4451-8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17483360/abstract/Thanatop:_a_novel_5_nitrofuran_that_is_a_highly_active_cell_permeable_inhibitor_of_topoisomerase_II_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/17483360/full_citation/Thanatop:_a_novel_5_nitrofuran_that_is_a_highly_active_cell_permeable_inhibitor_of_topoisomerase_II_">Full Citation</a> | <a href="http://cancerres.aacrjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=17483360">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/17483360/Thanatop:_a_novel_5_nitrofuran_that_is_a_highly_active_cell_permeable_inhibitor_of_topoisomerase_II_">Find Related Articles</a> </description></item><item><title>Low dose leflunomide activates PI3K/Akt signalling in erythroleukemia cells and reduces apoptosis induced by anticancer agents.</title><link>http://www.unboundmedicine.com/medline/ebm/record/16927021/full_citation/Low_dose_leflunomide_activates_PI3K/Akt_signalling_in_erythroleukemia_cells_and_reduces_apoptosis_induced_by_anticancer_agents_</link><description>Leger DY, Liagre B, Beneytout JL <br/><span class="title">Low dose leflunomide activates PI3K/Akt signalling in erythroleukemia cells and reduces apoptosis induced by anticancer agents. [JOURNAL ARTICLE]</span><br/><span class="source" title="">Apoptosis 2006 Aug 21.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/16927021/abstract/Low_dose_leflunomide_activates_PI3K/Akt_signalling_in_erythroleukemia_cells_and_reduces_apoptosis_induced_by_anticancer_agents_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/16927021/full_citation/Low_dose_leflunomide_activates_PI3K/Akt_signalling_in_erythroleukemia_cells_and_reduces_apoptosis_induced_by_anticancer_agents_">Full Citation</a></description></item><item><title>Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: Quality of life and 6-years'-follow-up results from a randomised phase III trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/16713013/full_citation/Efficient_palliation_in_patients_with_small_cell_lung_cancer_by_a_combination_of_paclitaxel_etoposide_and_carboplatin:_Quality_of_life_and_6_years'_follow_up_results_from_a_randomised_phase_III_trial_</link><description>Reck M, von Pawel J, Macha HN, et al. <br/><span class="title">Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: Quality of life and 6-years'-follow-up results from a randomised phase III trial. [Journal Article]</span><br/><span class="source" title="Lung cancer (Amsterdam, Netherlands)  ">Lung Cancer 2006 Jul; 53(1):67-75.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/16713013/abstract/Efficient_palliation_in_patients_with_small_cell_lung_cancer_by_a_combination_of_paclitaxel_etoposide_and_carboplatin:_Quality_of_life_and_6_years'_follow_up_results_from_a_randomised_phase_III_trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/16713013/full_citation/Efficient_palliation_in_patients_with_small_cell_lung_cancer_by_a_combination_of_paclitaxel_etoposide_and_carboplatin:_Quality_of_life_and_6_years'_follow_up_results_from_a_randomised_phase_III_trial_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0169-5002(06)00177-2">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/16713013/Efficient_palliation_in_patients_with_small_cell_lung_cancer_by_a_combination_of_paclitaxel_etoposide_and_carboplatin:_Quality_of_life_and_6_years'_follow_up_results_from_a_randomised_phase_III_trial_">Find Related Articles</a> </description></item><item><title>Camptothecin and podophyllotoxin derivatives : inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile.</title><link>http://www.unboundmedicine.com/medline/ebm/record/16524321/full_citation/Camptothecin_and_podophyllotoxin_derivatives_:_inhibitors_of_topoisomerase_I_and_II___mechanisms_of_action_pharmacokinetics_and_toxicity_profile_</link><description>Hartmann JT, Lipp HP <br/><span class="title">Camptothecin and podophyllotoxin derivatives : inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile. [Journal Article]</span><br/><span class="source" title="Drug safety :  an international journal of medical toxicology and drug experience.">Drug Saf 2006; 29(3):209-30.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/16524321/abstract/Camptothecin_and_podophyllotoxin_derivatives_:_inhibitors_of_topoisomerase_I_and_II___mechanisms_of_action_pharmacokinetics_and_toxicity_profile_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/16524321/full_citation/Camptothecin_and_podophyllotoxin_derivatives_:_inhibitors_of_topoisomerase_I_and_II___mechanisms_of_action_pharmacokinetics_and_toxicity_profile_">Full Citation</a> | <a href="http://openurl.ingenta.com/content/nlm%3fgenre=article%26amp;issn=0114-5916%26amp;volume=29%26amp;issue=3%26amp;spage=209%26amp;aulast=Hartmann">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/16524321/Camptothecin_and_podophyllotoxin_derivatives_:_inhibitors_of_topoisomerase_I_and_II___mechanisms_of_action_pharmacokinetics_and_toxicity_profile_">Find Related Articles</a> </description></item><item><title>Long-term visual outcome following chemoreduction for retinoblastoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/16286614/full_citation/Long_term_visual_outcome_following_chemoreduction_for_retinoblastoma_</link><description>Demirci H, Shields CL, Meadows AT, et al. <br/><span class="title">Long-term visual outcome following chemoreduction for retinoblastoma. [Journal Article]</span><br/><span class="source" title="Archives of ophthalmology.">Arch Ophthalmol 2005 Nov; 123(11):1525-30.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/16286614/abstract/Long_term_visual_outcome_following_chemoreduction_for_retinoblastoma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/16286614/full_citation/Long_term_visual_outcome_following_chemoreduction_for_retinoblastoma_">Full Citation</a> | <a href="http://archopht.ama-assn.org/cgi/pmidlookup%3fview=long%26amp;pmid=16286614">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/16286614/Long_term_visual_outcome_following_chemoreduction_for_retinoblastoma_">Find Related Articles</a> </description></item></channel></rss>